To investigate whether specific profiles on DWI and PWI predict a favorable clinical response to intravenous t-PA therapy administered between 3 and 6 hours after stroke onset.
- Tissue plasminogen activator (Activase®)Drug
Intervention Desc: Thrombolytic
Open label, multi-center, pilot study.
Patient needs baseline MR or CT prior to start of tPA. Second MRI 3 to 6 hours after initial bolus of tPA.
|Type||Measure||Time Frame||Safety Issue|
|No outcomes associated with this trial.|